MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 204 filers reported holding MYRIAD GENETICS INC in Q2 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $517,084 | -43.1% | 21,140 | -50.4% | 0.02% | -45.7% |
| Q1 2024 | $909,000 | +46.0% | 42,636 | +31.1% | 0.04% | +29.6% |
| Q4 2023 | $622,701 | -0.0% | 32,534 | -16.2% | 0.03% | -20.6% |
| Q3 2023 | $622,978 | -32.7% | 38,839 | -2.7% | 0.03% | -32.0% |
| Q2 2023 | $925,462 | +9.5% | 39,925 | +9.7% | 0.05% | -3.8% |
| Q1 2023 | $845,502 | +282.6% | 36,397 | +315.4% | 0.05% | +477.8% |
| Q1 2022 | $221,000 | -0.9% | 8,761 | +8.3% | 0.01% | +28.6% |
| Q4 2021 | $223,000 | -17.4% | 8,089 | -3.1% | 0.01% | -22.2% |
| Q3 2021 | $270,000 | -15.9% | 8,348 | -20.4% | 0.01% | -18.2% |
| Q2 2021 | $321,000 | +10.3% | 10,490 | +9.6% | 0.01% | 0.0% |
| Q1 2021 | $291,000 | +17.3% | 9,572 | -56.3% | 0.01% | -21.4% |
| Q2 2020 | $248,000 | -6.4% | 21,893 | +18.2% | 0.01% | -30.0% |
| Q1 2020 | $265,000 | -63.6% | 18,521 | -30.8% | 0.02% | -37.5% |
| Q4 2019 | $729,000 | -3.2% | 26,762 | +1.8% | 0.03% | -15.8% |
| Q3 2019 | $753,000 | +9.8% | 26,289 | +6.5% | 0.04% | +15.2% |
| Q2 2019 | $686,000 | -24.6% | 24,683 | -10.0% | 0.03% | -25.0% |
| Q1 2019 | $910,000 | +7.9% | 27,413 | -5.5% | 0.04% | -15.4% |
| Q4 2018 | $843,000 | -51.3% | 29,013 | -22.9% | 0.05% | -21.2% |
| Q3 2018 | $1,731,000 | +25.1% | 37,625 | +1.6% | 0.07% | +20.0% |
| Q2 2018 | $1,384,000 | +26.9% | 37,025 | +0.3% | 0.06% | +27.9% |
| Q1 2018 | $1,091,000 | -10.7% | 36,918 | +3.8% | 0.04% | -8.5% |
| Q4 2017 | $1,222,000 | -15.7% | 35,582 | -11.2% | 0.05% | -21.7% |
| Q3 2017 | $1,450,000 | +55.7% | 40,084 | +11.3% | 0.06% | +42.9% |
| Q2 2017 | $931,000 | +14.8% | 36,028 | -14.7% | 0.04% | +16.7% |
| Q1 2017 | $811,000 | +48.3% | 42,215 | +28.6% | 0.04% | +44.0% |
| Q4 2016 | $547,000 | -29.4% | 32,814 | -12.8% | 0.02% | -32.4% |
| Q3 2016 | $775,000 | -35.9% | 37,635 | -4.8% | 0.04% | -37.3% |
| Q2 2016 | $1,209,000 | -23.4% | 39,525 | -6.2% | 0.06% | -28.0% |
| Q1 2016 | $1,578,000 | -28.2% | 42,154 | -17.3% | 0.08% | -21.2% |
| Q4 2015 | $2,199,000 | +14.5% | 50,947 | -0.6% | 0.10% | -4.6% |
| Q3 2015 | $1,921,000 | +3.9% | 51,243 | -5.8% | 0.11% | +41.6% |
| Q2 2015 | $1,849,000 | -2.4% | 54,401 | +1.7% | 0.08% | +4.1% |
| Q1 2015 | $1,894,000 | +6.9% | 53,490 | +2.8% | 0.07% | +1.4% |
| Q4 2014 | $1,772,000 | -1.2% | 52,037 | +12.0% | 0.07% | -13.1% |
| Q3 2014 | $1,793,000 | +5.0% | 46,481 | +5.9% | 0.08% | +12.0% |
| Q2 2014 | $1,708,000 | -7.0% | 43,896 | -18.3% | 0.08% | -9.6% |
| Q1 2014 | $1,836,000 | +93.7% | 53,707 | +18.9% | 0.08% | +97.6% |
| Q4 2013 | $948,000 | +2.9% | 45,184 | +15.3% | 0.04% | -14.3% |
| Q3 2013 | $921,000 | -8.2% | 39,183 | +5.0% | 0.05% | -31.0% |
| Q2 2013 | $1,003,000 | – | 37,317 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
| Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
| ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
| EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
| AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
| Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
| Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |